China Shineway Pharmaceutical (02877) said total turnover of the Group for the three months ended 31 March 2016 dropped about 14.7% as compared with the same period of 2015 to about Rmb466 million.
In terms of product mix, injection products, soft capsule products and granule products accounted for about 53.6%, 20.4% and 20.8% of the total turnover respectively, all of which have not been reviewed by the auditors, for the first three months of 2016.